These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17464149)

  • 1. Blood and plasma treatments: the rationale of high-volume hemofiltration.
    Honoré PM; Joannes-Boyau O; Gressens B
    Contrib Nephrol; 2007; 156():387-95. PubMed ID: 17464149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood and plasma treatments: high-volume hemofiltration--a global view.
    Honoré PM; Joannes-Boyau O; Gressens B
    Contrib Nephrol; 2007; 156():371-86. PubMed ID: 17464148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The big bang of hemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification!
    Honore' PM; Joannes-Boyau O; Merson L; Boer W; Piette V; Galloy AC; Janvier G
    Int J Artif Organs; 2006 Jul; 29(7):649-59. PubMed ID: 16874669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do we need extracorporeal blood purification for sepsis and septic shock?
    Simoni J
    Artif Organs; 2019 May; 43(5):444-447. PubMed ID: 30908693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coupled plasma filtration adsorption: rationale and perspectives in septic shock].
    Page M; Rimmelé T
    Can J Anaesth; 2008 Dec; 55(12):847-52. PubMed ID: 19050088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments.
    Tetta C; Mariano F; Buades J; Ronco C; Wratten ML; Camussi G
    Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S57-65. PubMed ID: 9372980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs.
    Rimmelé T; Assadi A; Cattenoz M; Desebbe O; Lambert C; Boselli E; Goudable J; Etienne J; Chassard D; Bricca G; Allaouchiche B
    Nephrol Dial Transplant; 2009 Feb; 24(2):421-7. PubMed ID: 18799607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury.
    Honoré PM; Jacobs R; Boer W; Joannes-Boyau O; De Regt J; De Waele E; Van Gorp V; Collin V; Spapen HD
    Blood Purif; 2012; 33(1-3):44-51. PubMed ID: 22179226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the synergistic effects of high-volume haemofiltration and enhanced adsorption the missing key in sepsis modulation?
    Joannes-Boyau O; Honore PM; Boer W; Collin V
    Nephrol Dial Transplant; 2009 Feb; 24(2):354-7. PubMed ID: 19054800
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous plasma filtration coupled with sorbents.
    Tetta C; Cavaillon JM; Camussi G; Lonnemann FG; Brendolan A; Ronco C
    Kidney Int Suppl; 1998 May; 66():S186-9. PubMed ID: 9573601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design.
    Honoré PM; Matson JR
    Crit Care; 2002 Oct; 6(5):394-6. PubMed ID: 12398774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemofiltration treatment for sepsis: is it time for controlled trials?
    Rogiers P
    Kidney Int Suppl; 1999 Nov; (72):S99-103. PubMed ID: 10560816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupled plasma filtration adsorption.
    Formica M; Inguaggiato P; Bainotti S; Wratten ML
    Contrib Nephrol; 2007; 156():405-10. PubMed ID: 17464151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood purification in sepsis: a new paradigm.
    Peng Z; Singbartl K; Simon P; Rimmelé T; Bishop J; Clermont G; Kellum JA
    Contrib Nephrol; 2010; 165():322-328. PubMed ID: 20427984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupled plasma filtration adsorption.
    Bellomo R; Tetta C; Brendolan A; Ronco C
    Blood Purif; 2002; 20(3):289-92. PubMed ID: 11867877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-volume hemofiltration does not protect human kidney endothelial and tubular epithelial cells from septic plasma-induced injury.
    Medica D; Quercia AD; Marengo M; Fanelli V; Castellano G; Fabbrini P; Migliori M; Merlotti G; Camussi G; Joannes-Boyau O; Honorè PM; Cantaluppi V
    Sci Rep; 2024 Aug; 14(1):18323. PubMed ID: 39112634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis.
    Di Carlo JV; Alexander SR
    Int J Artif Organs; 2005 Aug; 28(8):777-86. PubMed ID: 16211527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study.
    Kade G; Lubas A; Rzeszotarska A; Korsak J; Niemczyk S
    Med Sci Monit; 2016 Nov; 22():4338-4344. PubMed ID: 27840404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent high permeability hemofiltration in septic patients with acute renal failure.
    Morgera S; Rocktäschel J; Haase M; Lehmann C; von Heymann C; Ziemer S; Priem F; Hocher B; Göhl H; Kox WJ; Buder HW; Neumayer HH
    Intensive Care Med; 2003 Nov; 29(11):1989-95. PubMed ID: 12955174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine removal during continuous hemofiltration in septic patients.
    De Vriese AS; Colardyn FA; Philippé JJ; Vanholder RC; De Sutter JH; Lameire NH
    J Am Soc Nephrol; 1999 Apr; 10(4):846-53. PubMed ID: 10203370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.